1. A genetic polymorphism of the N-oxidation of trimethylamine in humans;Al-Waiz;Clin. Pharmacol. Ther.,1987
2. N-Acetylation pharmacogenetics. Michaelis–Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo;Andres;Drug. Metab. Disp.,1986
3. Purification, physicochemical, and kinetic properties of liver acetyl-CoA: arylamine N-acetyltransferase from rapid acetylator rabbits;Andres;Mol. Pharmacol.,1987
4. On the active site of liver acetyl-CoA;Andres;J. Biol. Chem.,1988
5. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer;Ayesh;Nature,1984